The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Jan 2020 18:10

RNS Number : 5081A
DeepMatter Group PLC
21 January 2020
 

DeepMatter Group plc

("DeepMatter", the "Company" or "the Group")

 

Director/ PDMR Shareholding

 

DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, has been informed that on 21 January 2020 James Ede-Golightly, Non-Executive Chairman of the Company, transferred 2,324,544 ordinary shares of 0.01 pence each ("Ordinary Shares") in the Company at a price of 1.9506p per Ordinary Share from his direct holding in the Company into his Self-Invested Personal Pension (SIPP).

 

Following the transfer, Mr Ede-Golightly's interest in the Company remains at 2,680,249 Ordinary Shares, representing 0.36 per cent. of the issued share capital.

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1. Details of the person discharging managerial responsibilities / person closely associated

a

Name

James Ede-Golightly

 

 

 

 

2. Reason for notification

b

Position/Status

 

 

 

 

 

 

 

Non-Executive Chairman

c

Initial notification / amendment

Initial Notification

 

 

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a

Name

DeepMatter Group Plc

 

 

b

LEI

213800WSAEORFSGUAB87

 

 

4. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a

Description of the financial [Indication as to the nature of the instrument, type of instrument.

 

 

Identification Code

Ordinary Shares of 0.01p each

 

 

 

 

GB00B29YYY86

 

b

Nature of the transaction

Transfer into SIPP

(Sale in own name, purchase by SIPP)

 

 

c

Price (s) and volume (s)

 

Price (s)

Volumes (s)

1.95p (Sale from own name to SIPP)

2,324,544

1.9506p (Purchase by SIPP from own name)

2,324,544

 

 

d

Aggregated Information

 

- Aggregated Volume

- Price

Aggregation is N/A as sale and purchase were one trade each

e

Date of the transaction

21.01.20

f

Place of the transaction

London Stock Exchange (XLON)

    

 

For more information, please contact:

 

DeepMatter Group plc

T: 0141 548 8156

Mark Warne, Chief Executive Officer

 

 

 

 

Shore Capital (Nominated Adviser and Broker)

 

T: 020 7408 4050

Tom Griffiths

David Coaten

 

 

 

Alma PR

Caroline Forde

Jessica Joynson

Kieran Breheny

 

T: 020 3405 0205

deepmatter@almapr.co.uk

 

 About DeepMatter Group plc

 

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware™, to scientists across research and process development sectors.

 

The DigitalGlassware™ platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.

 

Visit: www.deepmatter.io and follow @deepmattergroup

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBIGDBIGDDGGB
Date   Source Headline
22nd Mar 201910:39 amRNSHolding(s) in Company
20th Mar 20197:00 amRNSDirectors' Shareholdings
19th Mar 20194:52 pmRNSReplacement - Total Voting Rights and Notice of...
19th Mar 20193:35 pmRNSHolding(s) in Company
19th Mar 20193:32 pmRNSHolding(s) in Company
15th Mar 20198:10 amRNSTotal Voting Rights and Notice of Results
12th Mar 20197:00 amRNSGrant of Options
11th Mar 201912:58 pmRNSResult of Meeting & Directorate Change
7th Mar 20199:00 amRNSIssue of Equity
25th Feb 20197:00 amRNSAcquisition, Placing & Waiver of Rule 9
14th Feb 20193:58 pmRNSHolding(s) in Company
6th Feb 20194:42 pmRNSHolding(s) in Company
6th Feb 20194:41 pmRNSHolding(s) in Company
17th Jan 20197:00 amRNSDisposal of SICM business
20th Dec 20187:00 amRNSUpdate, Conditional Acquisition & Proposed Placing
30th Nov 20187:00 amRNSPublication of Paper in leading Journal
6th Sep 20183:06 pmRNSExercise of Options and Issue of Equity
6th Sep 20187:00 amRNSInterim Results
15th Aug 20187:00 amRNSFurther Pioneer Agreements and Notice of Results
19th Jul 20187:00 amRNSPublication of Scientific Paper
11th Jun 20187:00 amRNSDirectorate Changes
11th Jun 20187:00 amRNSIssue of Equity
16th May 201811:45 amRNSResult of AGM, name change and new website
24th Apr 20187:00 amRNSDirector Dealing
19th Apr 20187:00 amRNSSecond Pioneer Agreement Signed
12th Apr 20187:00 amRNSFirst Pioneer Agreement Signed
5th Apr 20183:28 pmRNSDirector Dealing
28th Mar 20187:00 amRNSFinal results for the year ended 31 December 2017
6th Feb 20187:00 amRNSMoUs signed with pioneers
19th Jan 20189:00 amRNSPublication of Scientific Paper
17th Jan 20187:00 amRNSPublication of Scientific Paper
6th Dec 20177:00 amRNSDirector Dealing
4th Dec 20177:00 amRNSNew Share Option Scheme and Grant to PDMR
1st Dec 20171:01 pmRNSDirectors' Dealing
28th Nov 20179:47 amRNSDirector Dealing
22nd Nov 20175:50 pmRNSHolding(s) in Company
20th Nov 201711:02 amRNSHolding(s) in Company
8th Nov 20178:11 amRNSCompletion of Acquisition, Appointment of Director
3rd Nov 20177:00 amRNSAcquisition of OpenIOLabs Limited
4th Oct 20177:00 amRNSChange of Adviser
12th Sep 20177:00 amRNSHalf-year Report
19th May 201711:34 amRNSResult of AGM
26th Apr 20177:00 amRNSDirectorate Changes
28th Mar 20177:00 amRNSFinal Results
16th Feb 20177:00 amRNSDigital Chemistry to be performed in space
31st Jan 20178:03 amRNSAdvisory Committee
31st Jan 20177:00 amRNSPresentation at Healthcare Conference
9th Jan 20177:00 amRNSDigitalGlasswareT
15th Sep 20167:00 amRNSHalf-year Report
12th May 201611:45 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.